Open Market Consultation: Next Generation Sequencing for personalised cancer therapy

Publication date
January 22, 2021
Deadline
March 1, 2021
Short description

Seven hospitals from Austria, Italy, Germany, the Netherlands and France are inviting potentially interested bidders to participate in the open market consultation for their upcoming pre-commercial procurement on Next Generation Sequencing (NGS). The aim is to develop and test two fully integrated, standardized NGS workflows, from sample-pre-analytics to medical decision making, for routine diagnostics of common and rare cancers from adults and children. The open market consultation is planned to take place 22-23 March 2021 in Vienna. Registration deadline: 1 March 2020.

 

The open market consultation will be organised in the preferred form of a central face-to-face meeting, if the situation allows, combined with explanatory webinars and a questionnaire (otherwise in the form of a virtual meeting, combined with a webinar and a questionnaire).

If a face-to-face meeting is not possible due to the pandemic, the change to a virtual meeting will be announced via the project website (www.instandngs4p.eu) and the EC portal.

Please register by 01/03/2021 by emailing us at Instand-NGS4P@abgi-france.com, and  

please also indicate if you want to supply (under a non-disclosure agreement) additional confidential information that you do not wish to reveal in public during the open market consultation.

A questionnaire will be circulated after the OMC to collect detailed information from all the stakeholders, in preparation for the Call for Tenders.

Type
  • Other
Geographical focus
  • European Union (EU 28)
Scientifc field / Thematic focus
  • Cross-thematic/Interdisciplinary

Entry created by Admin WBC-RTI.info on February 15, 2021
Modified on February 15, 2021